Thiophene-2-carboximidamide
Names and Identifiers of Thiophene-2-carboximidamide
CAS Number |
54610-75-2 |
|---|---|
MDL Number |
MFCD00939263 |
IUPAC Name |
thiophene-2-carboximidamide |
InChI |
InChI=1S/C5H6N2S/c6-5(7)4-2-1-3-8-4/h1-3H,(H3,6,7) |
InChIKey |
QSELGEUCFNFITD-UHFFFAOYSA-N |
Canonical SMILES |
C1=CSC(=C1)C(=N)N |
UNSPSC Code |
12352100 |
Physical and chemical properties of Thiophene-2-carboximidamide
Boiling Point |
220.8ºC at 760 mmHg |
|---|---|
Density |
1.36g/cm3 |
Exact Mass |
126.02500 |
Flash Point |
87.3ºC |
H Bond Acceptors |
2 |
H Bond Donors |
2 |
Index of Refraction |
1.675 |
LogP |
1.83220 |
Molecular Formula |
C5H6N2S |
Molecular Weight |
126.18000 |
PSA |
78.11000 |
Safety Information of Thiophene-2-carboximidamide
Applications of Thiophene-2-carboximidamide
Thiophene-2-carboximidamide has several applications:
- Pharmaceutical Development: Its derivatives are being explored for their potential as therapeutic agents due to their biological activities.
- Chemical Research: Used as a building block in organic synthesis and material science.
- Agricultural Chemistry: Investigated for potential use in agrochemicals due to its biological properties.
Interaction Studies of Thiophene-2-carboximidamide
Research on thiophene-2-carboximidamide has focused on its interactions with various biological targets. Notably, studies have demonstrated its ability to selectively inhibit nitric oxide synthase isoforms, which is significant for drug design aimed at treating diseases involving nitric oxide dysregulation. Additionally, interaction studies have explored its binding affinities and mechanisms of action at the molecular level.
Biological Activity of Thiophene-2-carboximidamide
Thiophene-2-carboximidamide has shown promising biological activities, particularly as an inhibitor of nitric oxide synthase. This inhibition can have implications in various therapeutic areas, including cardiovascular diseases and inflammation. Studies have indicated that derivatives of thiophene-2-carboximidamide exhibit selective inhibition of different isoforms of nitric oxide synthase, which is crucial for developing targeted therapies.
